Evidence map›Paper›PMID 25822172›Full record

ArticlePloS one2015

Remodeling of the residual gastric mucosa after roux-en-y gastric bypass or vertical sleeve gastrectomy in diet-induced obese rats.

Konstantinos Arapis, Jean Baptiste Cavin, Laura Gillard, Françoise Cluzeaud, Philippe Lettéron, Robert Ducroc, Johanne Le Beyec, Muriel Hourseau, Anne Couvelard, Jean-Pierre Marmuse and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Enteroendocrine System and Gut Barrier in Metabolic Disorders.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Konstantinos ArapisInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France; Service de Chirurgie Générale et Digestive; Hôpital Bichat-Claude Bernard. Paris, France.
Jean Baptiste CavinInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Laura GillardInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Françoise CluzeaudInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Philippe LettéronInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Robert DucrocInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Johanne Le BeyecInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Muriel HourseauDHU Unity, Bichat-Beaujon AP-HP, Paris, France; Département de Pathologie; Hôpital Bichat-Claude Bernard, Paris, France.
Anne CouvelardInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France; Département de Pathologie; Hôpital Bichat-Claude Bernard, Paris, France.
Jean-Pierre MarmuseInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France; Service de Chirurgie Générale et Digestive; Hôpital Bichat-Claude Bernard. Paris, France.
Maude Le GallInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
André BadoInserm UMR 1149, UFR de Médecine Paris Diderot, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; DHU Unity, Bichat-Beaujon AP-HP, Paris, France.
Hôpital Beaujon · FRDélégation Paris 7 · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Bichat-Claude-Bernard · FRInserm · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whereas the remodeling of intestinal mucosa after bariatric surgeries has been the matter of numerous studies to our knowledge, very few reported on the remodeling of the residual gastric mucosa. In this study, we analyzed remodeling of gastric mucosa after Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) in rats. Diet-induced obese rats were subjected to RYGB, VSG or sham surgical procedures. All animals were assessed for food intake, body-weight, fasting blood, metabolites and hormones profiling, as well as insulin and glucose tolerance tests before and up to 5 weeks post-surgery. Remodeling of gastric tissues was analyzed by routine histology and immunohistochemistry studies, and qRT-PCR analyses of ghrelin and gastrin mRNA levels. In obese rats with impaired glucose tolerance, VSG and RYGB caused substantial weight loss and rats greatly improved their oral glucose tolerance. The remaining gastric mucosa after VSG and gastric pouch (GP) after RYGB revealed a hyperplasia of the mucous neck cells that displayed a strong immunoreactivity for parietal cell H+/K+-ATPase. Ghrelin mRNA levels were reduced by 2-fold in remaining fundic mucosa after VSG and 10-fold in GP after RYGB. In the antrum, gastrin mRNA levels were reduced after VSG in line with the reduced number of gastrin positive cells. This study reports novel and important observations dealing with the remaining gastric mucosa after RYGB and VSG. The data demonstrate, for the first time, a hyperplasia of the mucous neck cells, a transit cell population of the stomach bearing differentiating capacities into zymogenic and peptic cells.

Indexed as

AnimalsBlood GlucoseBody WeightDietEatingGastrectomyGastric BypassGastric MucosaGhrelinGlucose Tolerance TestH(+)-K(+)-Exchanging ATPaseInsulinMaleObesityRatsRats, WistarBlood GlucoseGhrelinH(+)-K(+)-Exchanging ATPaseInsulinRNA, Messenger

Identifiers

PMID25822172
PMCPMC4379088
OpenAlexW2083170869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.